Showing results (71-80 of 182) with videos related to
Sort By:
Pageof 19
Liver International : Official Journal of the International Association for the Study of the Liver|September 10, 2015
Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysisBasile Njei, Neil Gupta, Oforbuike Ewelukwa, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2013
Histologic changes in liver tissue from patients with chronic hepatitis B and minimal increases in levels of alanine aminotransferase: a meta-analysis and systematic reviewLong H Nguyen, David Chao, Joseph K Lim, et al.Scientific Reports|April 13, 2024
An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitisBasile Njei, Eri Osta, Nelvis Njei, et al.Scientific Reports|November 21, 2019
Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular CarcinomaWilliam M Kamp, Cortlandt M Sellers, Stacey Stein, et al.Journal of Vascular and Interventional Radiology : JVIR|May 8, 2020
Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular CarcinomaWilliam M Kamp, Cortlandt M Sellers, Stacey Stein, et al.Hepatology (Baltimore, Md.)|July 30, 2020
Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital NetworkMelanie A Hundt, Yanhong Deng, Maria M Ciarleglio, et al.Genes|September 28, 2023
Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisGeorge Chen, Bubu A Banini, Albert Do, et al.Current Gastroenterology Reports|September 28, 2023
Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical PracticeYsabel C Ilagan-Ying, Bubu A Banini, Albert Do, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2026
Hepatitis B Reactivation in a US Cohort of People With Human Immunodeficiency Virus and Hepatitis B Core Antibody After Switch to Antiretroviral Therapy Without Hepatitis B ActivityRachel V Denyer, Janet P Tate, Debra A Benator, et al.Journal of Clinical and Experimental Hepatology|April 18, 2025
No Differences in Risk of Cirrhosis or Hepatocellular Carcinoma Among Treatment Naïve Chronic Hepatitis B Patients by Baseline Hepatitis B Viral Load: A Propensity Score Weighted AnalysisZeyuan Yang, Ramsey C Cheung, Janice H Jou, et al.Pageof 19